Recruiting Pulmonary Embolism Studies in Miramar
CORE-OLE: A Study of Olezarsen (ISIS 678354) Administered Subcutaneously to Participants With Severe Hypertriglyceridemia (SHTG)
The purpose of this study is to evaluate the safety and tolerability of olezarsen in participants with SHTG....
A Research Study Comparing How Well Different Doses of the Medicine NNC0487-0111 Lower Blood Sugar in People With Type 2 Diabetes
The study will look at how well different doses of a new medicine called NNC0487-0111 help lower the blood sugar and body weight in people with type 2 diabetes. NNC0487-0111 is a new medicine which ca...
About Pulmonary Embolism Clinical Trials in Miramar
Pulmonary embolism (PE) is a blockage of an artery in the lungs, usually caused by blood clots that travel from the deep veins of the legs. It can be life-threatening and requires immediate medical attention. Treatment includes anticoagulants and in severe cases, thrombolytic therapy.
There are currently 2 pulmonary embolism clinical trials recruiting participants in Miramar, FLORIDA. These studies are seeking a combined 1,232 participants. Research is being sponsored by Ionis Pharmaceuticals, Inc., Novo Nordisk A/S. Clinical trial participation is free and participants receive study-related medical care at no cost.
Pulmonary Embolism Clinical Trials in Miramar — FAQ
Are there pulmonary embolism clinical trials in Miramar?
Yes, there are 2 pulmonary embolism clinical trials currently recruiting in Miramar, FLORIDA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Miramar?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Miramar research site will contact you about next steps.
Are clinical trials in Miramar free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Miramar studies also compensate for your time and travel.
What pulmonary embolism treatments are being tested?
The 2 active trials in Miramar are testing new therapies including novel drugs, biologics, and treatment approaches for pulmonary embolism.
Data updated March 2, 2026 from ClinicalTrials.gov